{"disease":{"id":"chronic-hepatitis-b-infection","name":"chronic hepatitis b infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07274345","title":"Prevalence and Risk Factors of Antiviral Resistance in Egyptian HBV Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Amira Mohamed Zidan","has_results":false},{"nct_id":"NCT06874127","title":"Non-Invasive Model for Fibrosis Regression in HBV Patients","phase":"","overall_status":"RECRUITING","enrollment_count":1100,"lead_sponsor_name":"Beijing Friendship Hospital","has_results":false},{"nct_id":"NCT06906016","title":"New HBV Infection Biomarkers: Clinical Characterization and Impact on Management","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04135235","title":"Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B","phase":"","overall_status":"UNKNOWN","enrollment_count":440,"lead_sponsor_name":"Beijing Ditan Hospital","has_results":false},{"nct_id":"NCT04030039","title":"Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned Intervention","phase":"","overall_status":"UNKNOWN","enrollment_count":420,"lead_sponsor_name":"Beijing Ditan Hospital","has_results":false},{"nct_id":"NCT06544551","title":"Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"Beijing Kawin Technology Share-Holding Co., Ltd.","has_results":false},{"nct_id":"NCT06537414","title":"A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":283,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT05382351","title":"Antiviral Therapy for Patients With Chronic Hepatitis B Infection","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":238,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07511218","title":"A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Ausper Biopharma Co., Ltd.","has_results":false},{"nct_id":"NCT05494528","title":"Comparing P1101 to Entecavir in Patients With HBeAg(-) Hepatitis B Under Long-term Nucleos(t)Ide Analogue Therapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT07389044","title":"A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"IntegerBio","has_results":false},{"nct_id":"NCT03587467","title":"Study on Gut Microbiota in Chronic HBV Infected Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Zhongshan Hospital Xiamen University","has_results":false},{"nct_id":"NCT07519330","title":"Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT05355467","title":"Efficacy and Safety of Ricovir® in Maintaining Durability of Viral Response in Chronic Hepatitis B Patients Who Have Been Treated With Viread® and Have Undetectable HBV DNA in Serum","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Mylan (Taiwan) Ltd","has_results":false},{"nct_id":"NCT07515209","title":"A Clinical Study of HH-006 in Untreated Chronic Hepatitis B Virus Infected Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT07342881","title":"Single Dose Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Participants With Renal Impairment and in Healthy Participants With Normal Renal Function","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Aligos Therapeutics","has_results":false},{"nct_id":"NCT04971512","title":"A 2 PART STUDY EVALUATING EDP-721 IN HEALTHY SUBJECTS AND EDP-721 IN COMBINATION WITH EDP-514 IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION.","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":26,"lead_sponsor_name":"Enanta Pharmaceuticals, Inc","has_results":false},{"nct_id":"NCT04638439","title":"The Safety and Efficacy of Sequential Treatment of Ropeginterferon Alfa-2b (P1101) and Anti-PD1 in Interferon-Naive Adults With Chronic Hepatitis B or D Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"PharmaEssentia","has_results":false},{"nct_id":"NCT05674448","title":"A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With Chronic Hepatitis B and Hepatitis D Co-infection","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"Huahui Health","has_results":false},{"nct_id":"NCT06159062","title":"A Clinical Study of 162 in Subjects With Chronic Hepatitis B Virus Infection","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Yangshengtang Co., Ltd","has_results":false}],"total":20},"guidelines":[],"source":"Drug Landscape verified database"}